NO981564D0 - Terapeutisk administrering av hemoglobin ved hjertestans - Google Patents

Terapeutisk administrering av hemoglobin ved hjertestans

Info

Publication number
NO981564D0
NO981564D0 NO981564A NO981564A NO981564D0 NO 981564 D0 NO981564 D0 NO 981564D0 NO 981564 A NO981564 A NO 981564A NO 981564 A NO981564 A NO 981564A NO 981564 D0 NO981564 D0 NO 981564D0
Authority
NO
Norway
Prior art keywords
hemoglobin
cardiac arrest
therapeutic administration
therapeutic
administration
Prior art date
Application number
NO981564A
Other languages
English (en)
Other versions
NO981564L (no
Inventor
Kenneth E Burhop
Moses S S Chow
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of NO981564L publication Critical patent/NO981564L/no
Publication of NO981564D0 publication Critical patent/NO981564D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO981564A 1995-10-06 1998-04-06 Terapeutisk administrering av hemoglobin ved hjertestans NO981564D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/540,115 US5733869A (en) 1995-10-06 1995-10-06 Therapeutic administration of hemoglobin in cardiac arrest
PCT/US1996/013512 WO1997012627A1 (en) 1995-10-06 1996-08-20 Therapeutic administration of hemoglobin in cardiac arrest

Publications (2)

Publication Number Publication Date
NO981564L NO981564L (no) 1998-04-06
NO981564D0 true NO981564D0 (no) 1998-04-06

Family

ID=24154065

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981564A NO981564D0 (no) 1995-10-06 1998-04-06 Terapeutisk administrering av hemoglobin ved hjertestans

Country Status (9)

Country Link
US (1) US5733869A (no)
EP (1) EP0853485A4 (no)
JP (1) JPH11512738A (no)
AU (1) AU710496B2 (no)
CA (1) CA2233917A1 (no)
NO (1) NO981564D0 (no)
TW (1) TW434022B (no)
WO (1) WO1997012627A1 (no)
ZA (1) ZA967915B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6213960B1 (en) * 1998-06-19 2001-04-10 Revivant Corporation Chest compression device with electro-stimulation
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
AU784195B2 (en) * 1999-11-12 2006-02-16 Baxter Biotech Technology S.A.R.L. Reduced side-effect hemoglobin compositions
IL153792A (en) * 2003-01-02 2007-08-19 Yissum Res Dev Co Method for increased production of hydroxyl radicals
US8805491B2 (en) * 2004-04-20 2014-08-12 Zoll Medical Corporation Microperfusive electrical stimulation
US9101779B2 (en) * 2006-10-19 2015-08-11 Uab Research Foundation Method and system for reducing cardiac low pressure states
US7494974B2 (en) * 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US9248093B2 (en) 2009-06-11 2016-02-02 Becton, Dickinson And Company Catheter locking solution having antimicrobial and anticoagulation properties
JP7387597B2 (ja) 2017-07-18 2023-11-28 ヴァーテック・バイオ・インコーポレイテッド ヘモグロビンを含む代用血液及び作製方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4757052A (en) * 1982-09-03 1988-07-12 Markov Angel K Method of preserving blood
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
FR2551660B1 (fr) * 1983-09-13 1986-11-14 Centre Nat Rech Scient Hemoglobine modifiee chimiquement, sa preparation, solutions aqueuses en contenant et leur utilisation
GB8328917D0 (en) * 1983-10-28 1983-11-30 Fisons Plc Blood substitute
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
USRE34271E (en) * 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US4798824A (en) * 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US5464814A (en) * 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5194590A (en) * 1986-06-20 1993-03-16 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5084558A (en) * 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
CA1312009C (en) * 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
ES2032802T5 (es) * 1986-11-10 2004-01-16 Biopure Corporation Sucedaneo de sangre semisintetico extrapuro.
US4866096A (en) * 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions
US5268500A (en) * 1987-06-15 1993-12-07 Montefiore Medical Center Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation
US4994444A (en) * 1987-07-31 1991-02-19 The Trustees Of Columbia In The City Of New York Macromolecules for sealing capillary endothelial junctions
US4988515A (en) * 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
IL87707A (en) * 1988-09-08 1994-06-24 Technion Inst For Research And Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof
IL87708A (en) * 1988-09-08 1994-04-12 Technion Inst For Research And Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof
FR2640141B1 (fr) * 1988-12-14 1993-04-16 Merieux Inst Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
US5173426A (en) * 1989-10-06 1992-12-22 Yale University DNAs encoding genetically engineered low oxygen affinity mutants of human hemoglobin
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
US5386014A (en) * 1989-11-22 1995-01-31 Enzon, Inc. Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
US5432191A (en) * 1990-02-12 1995-07-11 The Center For Innovative Technology Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
US5248785A (en) * 1990-02-12 1993-09-28 Virginia Commonwealth University Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
CA2036770C (en) * 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
US5306508A (en) * 1990-06-22 1994-04-26 The Regents Of The University Of California Red blood cell surrogate
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
US5413558A (en) * 1991-09-09 1995-05-09 New York University Selective aortic perfusion system for use during CPR
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
AU2198592A (en) * 1992-02-20 1993-09-13 Alliance Pharmaceutical Corporation Inhibition of bacterial endotoxin
CA2074852A1 (en) * 1992-07-29 1994-01-30 Ehud Ilan Organ perfusion hemoglobins
DK0693924T4 (da) * 1993-02-22 2008-08-04 Abraxis Bioscience Inc Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil

Also Published As

Publication number Publication date
AU6853196A (en) 1997-04-28
CA2233917A1 (en) 1997-04-10
NO981564L (no) 1998-04-06
EP0853485A1 (en) 1998-07-22
AU710496B2 (en) 1999-09-23
TW434022B (en) 2001-05-16
JPH11512738A (ja) 1999-11-02
ZA967915B (en) 1997-05-02
EP0853485A4 (en) 2000-11-02
US5733869A (en) 1998-03-31
WO1997012627A1 (en) 1997-04-10

Similar Documents

Publication Publication Date Title
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
DE69520403D1 (de) Herzrhythmusmessgerät
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
DK95091A (da) Anvendelse af acetyl-d-carnitin ved terapeutisk behandling af glaucoma
NO910340D0 (no) Topiske preparater for behandling av menneskenegler.
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
ATE210429T1 (de) Therapie mittels gleichförmiger arzneistoffverabreichung
FI972432A (fi) Titaani(II)- tai sirkonium(II)-kompleksien parannettu valmistus
NO171507C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater
FI965204A (fi) Bromelaiinin lääkekäyttö
NO981564L (no) Terapeutisk administrering av hemoglobin ved hjertestans
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
NO995231D0 (no) Terapeutisk behandling av hudlidelser
NO170021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater
NO981866L (no) Terapeutisk anvendelse av hemoglobin for Õ fremme sÕrheling
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
NO172115C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bronkospasmolytiske forbindelser
NO20001895D0 (no) Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application